within Pharmacolibrary.Drugs.ATC.J;

model J01CA13
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 8.1 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 3000 / 1000000,
    adminCount     = 1,
    Vd             = 0.015,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Ticarcillin is a broad-spectrum, semi-synthetic penicillin antibiotic primarily used for the treatment of infections caused by susceptible Gram-negative and some Gram-positive bacteria. It is historically used in the management of serious infections such as those due to Pseudomonas aeruginosa. Ticarcillin is often combined with clavulanic acid to overcome beta-lactamase-mediated resistance. It has largely been replaced by other agents in many therapeutic settings, but may still be used in some hospitals.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics in healthy adult volunteers following intravenous administration.</p><h4>References</h4><ol><li><p>Dulhunty, JM, et al., &amp; Lipman, J (2015). A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis. <i>American journal of respiratory and critical care medicine</i> 192(11) 1298–1305. DOI:<a href=&quot;https://doi.org/10.1164/rccm.201505-0857OC&quot;>10.1164/rccm.201505-0857OC</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26200166/&quot;>https://pubmed.ncbi.nlm.nih.gov/26200166</a></p></li><li><p>Wilson, WD, et al., &amp; Pryor, P (1991). Pharmacokinetics and bioavailability of ticarcillin and clavulanate in foals after intravenous and intramuscular administration. <i>Journal of veterinary pharmacology and therapeutics</i> 14(1) 78–89. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2885.1991.tb00807.x&quot;>10.1111/j.1365-2885.1991.tb00807.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2038098/&quot;>https://pubmed.ncbi.nlm.nih.gov/2038098</a></p></li><li><p>Dulhunty, JM, et al., &amp; Lipman, J (2013). Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial. <i>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</i> 56(2) 236–244. DOI:<a href=&quot;https://doi.org/10.1093/cid/cis856&quot;>10.1093/cid/cis856</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/23074313/&quot;>https://pubmed.ncbi.nlm.nih.gov/23074313</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J01CA13;
